Dane Leone

Stock Analyst at Raymond James

(0.76)
# 2363
Out of 5,358 analysts
128
Total ratings
32.65%
Success rate
0.60%
Average return
42 Stocks
Name Action PT Current % Upside Ratings Updated
XLO Xilio Therapeutics
Maintains: Outperform
6 4
0.7 471.43% 3 Nov 8, 2024
RGNX Regenxbio
Reinstates: Outperform
45
9.6 368.75% 2 Feb 21, 2024
BPMC Blueprint Medicines
Maintains: Strong Buy
85 100
127.82 -21.76% 9 Dec 22, 2023
RVMD Revolution Medicines
Initiates Coverage On: Outperform
30
41.1 -27.01% 1 Nov 16, 2023
BLUE bluebird bio
Maintains: Outperform
200 260
4.97 5131.39% 6 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
950
493.12 92.65% 10 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
n/a n/a 3 Oct 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
13
1.9 584.21% 5 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 46
38.61 19.14% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
69
27.75 148.65% 5 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 8
n/a n/a 5 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
29
3.35 765.67% 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 8
2.5 220% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 14
9.03 55.04% 5 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
58
9.65 501.04% 4 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 70
27.52 154.36% 3 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 63
32.32 94.93% 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 6
n/a n/a 2 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
43.84 48.27% 3 Oct 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Dec 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
255
290.34 -12.17% 3 Oct 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 5 Dec 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
3.53 806.52% 2 Sep 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jul 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 3 Jun 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 Dec 22, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
n/a n/a 1 Sep 23, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 7, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Sep 5, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 2 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 15, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 11, 2016